Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2018 FY- Text added to 2019 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
abatement, adult, AstraZeneca, autonomic, Avanir, bankruptcy, BioPharma, blister, Braeburn, Cambrex, Cambridge, cancelable, Casey, cautioned, chapter, constitute, contend, covenant, cybersecurity, Dealer, depict, downstream, embedded, Enfield, excise, floor, forthcoming, fundamental, Gallatin, Hahnemann, Haven, heard, hereto, herewith, indenture, IRC, Janssen, jointly, lender, LIBOR, Lock, LP, Malamut, margin, Mellon, metric, Middletown, milligram, Minnesota, modification, NaN, Natick, neurodegenerative, neurologist, neuromuscular, nonlease, Norwich, Paterson, pivotal, Portsmouth, preserve, PSU, Randolph, ratably, remand, repaid, Richard, robust, seventeen, sharp, situated, Squibb, statue, thereunder, Township, translational, Trenton, Triad, Trinity, Trust, trustee, unbenefited, unchanged, unsecured, vehicle, Warminster, Warrington, Wethersfield, Zyla
Removed:
accelerate, antagonist, API, beneficially, breakthrough, buccal, capitalizing, chewed, coincide, complementary, complying, compute, crystalline, Dedham, desire, dissolved, DOJ, dysphagia, earn, EEA, Egalet, emerging, entrench, exert, expanded, factor, feel, film, formation, golden, HITECH, ICH, initiating, innovator, integrating, intensely, IPO, IRB, lessee, milestone, motivating, naltrexone, NQs, OP, opening, organizational, parachute, Park, pathway, peak, pediatric, percent, permanently, persuading, powder, prevailing, privately, profit, resolve, retained, Senate, soluble, speak, substitution, successor, suspended, takeover, Targiniq, tenant, TIRF, Transmucosal, Troxyca, unintended, unsolicited, upper, Vantrela, white, withdrawn
Valuein 2018 FY filing- Value in 2019 FY filing
Original filings
Filing view